Welcome to the IVX Health Newsroom. Here, you can find the latest news on our company, including future market expansions, leadership updates, new formulary offerings and more.
Press Releases
INDIANAPOLIS, Feb. 16, 2021 - IVX Health, a national provider of infusion and injection therapy for patients with multiple sclerosis, Crohn’s disease, ulcerative colitis, and other complex chronic conditions, today announced the opening of three new centers in the Indianapolis metropolitan area.
COLUMBUS, Ohio, Dec. 1, 2020 - IVX Health, a national provider of infusion and injection therapy for patients with Crohn’s disease, multiple sclerosis, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of its third center in the greater Columbus area — conveniently located in Grove City.
IVX Health, a national provider of infusion and injection therapy for patients with multiple sclerosis, Crohn's disease, ulcerative colitis, and other complex chronic conditions, today announced the opening of two new centers in the Chicago metropolitan area. Conveniently located in the communities of Lombard and Naperville, IVX Health offers patients an alternative to hospital-based infusions – with the same high-quality standards and safety protocols. IVX Health reimagines the traditional experience for infusion patients with amenities such as guaranteed private suites that allow for proper social distancing – a meaningful benefit when considering the often hours-long infusion procedures. IVX Health is now accepting patients in both of its new Chicago locations, adding to its existing footprint of Chicago-based centers conveniently located in Glenview and Schaumburg.
October 14th, 2020–IVX Health, a national provider of infusion and injection therapy for patients with complex chronic conditions such as multiple sclerosis, Crohn’s disease, and rheumatoid arthritis, announced today its acquisition of Precision Healthcare, formerly a subsidiary of BAI Healthcare Services, Inc. Based in Nashville, Tenn., Precision operates 12 infusion centers across Tennessee and northern Arkansas. The acquisition financing was led by a preferred equity investment from Linden Capital Partners – a Chicago-based private equity firm focused exclusively on the healthcare sector – and joined by existing institutional investors McKesson Ventures, Health Velocity Capital, and Nueterra Capital.
Modern Healthcare has named IVX Health as one of the Best Places to Work in Healthcare in 2020, an annual program that identifies and honors 150 outstanding employers in the healthcare industry nationwide. Modern Healthcare ranked IVX Health No. 20 overall in one of its two category designations.
IVX Health, a national provider of infusion and injection therapy for patients with Crohn’s disease, multiple sclerosis, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of three new centers in the Tampa metropolitan area.
IVX Health, a national provider of infusion and injection therapy for patients with Crohn’s disease, multiple sclerosis, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of two new centers in the Orlando metropolitan area.
July 22nd, 2020–IVX Health, a national provider of infusion and injection therapy for patients with autoimmune disorders such as multiple sclerosis and other complex chronic conditions, today announced the expansion of its infusion formulary with the addition of VYEPTI™ (eptinezumab-jjmr), the first FDA-approved IV preventive treatment for migraines in adults.
IVX Health, a national provider of infusion and injection therapy for patients with Crohn’s disease, multiple sclerosis, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of two new centers in the Cincinnati metropolitan area.
IVX Health, a national network of patient-focused care centers providing biologic infusion and injection therapy, is collaborating with hospitals and health systems across the country to ensure a safe, accessible site of care for immunocompromised patients during the COVID-19 pandemic.
In the News
October 30, 2020
Brentwood-based IVX Health doubles its Chicago footprint
IVX Health said it’s opening locations in Lombard and Naperville to go along with its existing Chicagoland locations in Glenview and Schaumburg.
October 29, 2020
IVX Health Opens Two New Infusion Centers in Chicago to Serve Patients with Complex Chronic Conditions
IVX Health, a national provider of infusion and injection therapy for patients with multiple sclerosis, Crohn’s disease, ulcerative colitis, and other complex chronic conditions, today announced the opening of two new centers in the Chicago metropolitan area.
October 26, 2020
IVX Health Completes Acquisition Of Precision Healthcare
IVX Health, a national provider of infusion and injection therapy for patients with complex chronic conditions such as multiple sclerosis, Crohn’s disease, and rheumatoid arthritis, announced its acquisition of Precision Healthcare, formerly a subsidiary of BAI Healthcare Services, Inc.
October 15, 2020
Linden Supports IVX’s Acquisition of Precision Healthcare
Linden Capital Partners has made an investment in IVX Health, a provider of infusion and injection therapy for patients with complex chronic conditions.
October 15, 2020
IVX Health Buys Local Peer with PE Funding
Nashville-based infusion services company IVX Health has bought a local competitor with backing from a private equity firm based in Chicago. Led by Linden Capital Partners and joined by existing investors McKesson Ventures, Health Velocity Capital and Nueterra Capital, fast-growing IVX has acquired Precision Healthcare from its parent company BAI Healthcare Services.
October 14, 2020
IVX Health buys fellow Middle Tennessee infusion center operator Precision Healthcare
IVX Health is widening its reach in the Southeast. The Brentwood-based company, which operates infusion centers for patients with chronic conditions, has purchased Nashville-based Precision Healthcare from BAI Healthcare Services Inc., according to a news release. Terms of the deal were not disclosed.
July 14, 2020
National health care provider opens locations in Oakley, Colerain
IVX Health, a national provider of biologic infusion and injection therapy for patients with chronic autoimmune illnesses such as multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease, has opened its first locations in Cincinnati.
December 30, 2019
Healthcare leaders reflect on major trends in 2019
Doug Ghertner, CEO of IVX Health, said the increased emphasis on consumerization in healthcare over the last two years is likely to continue into 2020. He said that the patient experience needs to “be fundamentally better and different than it’s been in the past.”
November 27, 2019
IVX Health opens two centers in central Pa.
PENNSYLVANIA, Pa. — Two centers opened this month in the midstate that will provide biologic infusion and injection therapy.
IVX Health opened the two facilities at Hampden Shops at 4957 Carlisle Pike in Hampden Township and at Olde Liberty Square, 4813 Jonestown Road in Lower Paxton Township.
August 6, 2019
Brentwood company led by former Change Healthcare CEO raises $22.5M
NASHVILLE, Tenn. — A health care company that recently moved its headquarters from Kansas City to Brentwood has raised fresh capital to help double its national footprint.
Infusion Express, which is changing its name to IVX Health, has completed a $22.5 million round of funding, led by McKesson Ventures and Health Velocity Capital, the company announced Monday. CEO Doug Ghertner said IVX Health, which operates infusion centers for patients with chronic conditions, will use the funds to open as many as 10 new locations by the end of the year, giving the company a total of 20 facilities.
August 6, 2019
Infusion Express lands $22.5M growth injection
NASHVILLE, Tenn. — Pharmaceutical infusion center operator Infusion Express has received a $22.5 million round of growth funding and rebranded as IVX Health.
The Brentwood-based company raised the capital to continue expansion in existing markets and new locations. McKesson Ventures and Health Velocity Capital, both of which led a $13.5 million round in 2017, co-led this most recent funding round. Other funders include Nueterra Capital and CrimsoNox Capital.
June 12, 2019
Infusion Centers Help Navigate Cost of Care
AUSTIN, Texas — The number of ambulatory infusion centers is growing as more payers refuse to cover biologic infusions for patients with chronic illnesses in hospitals because of the higher costs.
“We tend to be half the cost of the hospital,” said Doug Ghertner, chief executive officer of IVX Health, which has 10 centers in and around Chicago, Kansas City, Philadelphia, and the San Francisco Bay Area.
May 13, 2019
Modern Healthcare Recognizes IVX Health as one of the Best Places to Work in Healthcare in 2019
CHICAGO, Illi., May 13, 2019 — IVX Health, a patient-focused alternative to hospital-based infusion centers, has been selected by Modern Healthcare as one of the 2019 Best Places to Work in Healthcare. The complete list of this year’s winners, in alphabetical order, is available here. Modern Healthcare will publish a special supplement featuring ranked lists of all the winners along with the September 30 issue.
Feb 22nd, 2018
New CEO succeeds founder at one of KC’s fastest-growing companies
KANSAS CITY, Missouri., Feb 22, 2018 /Kansas City Business Journal/ — Don Peterson, who previously was CEO of IVX Health, founded the company just five years ago. Now, he’s stepping back to let someone with more industry know-how steer the Kansas City area’s third-fastest-growing company.
Feb 7th, 2018
Former Change Healthcare CEO leading infusion venture
NASHVILLE, Tenn., Feb 7, 2018 /Nashville Post/ — Former Change Healthcare executive Doug Ghertner has been hired to run an infusion services company that last fall landed $13.5 million in backing from three firms.
Media Inquiries
Chase Pattison
Vice President, Marketing
[email protected]
Headquarters
IVX Health
214 Centerview Drive
Suite 250
Brentwood, TN 37027
Click here to find an IVX Health center near you.